Based on interviews and record reviews, 1) the facility failed to ensure the attending physician reviewed and responded to the identified irregularities on the pharmacist Medication Regimen Review (MRR) for one of five residents R91) sampled for medication review. The pharmacist identified an irregularity for a resident prescribed a psychotropic medication without a diagnosis and recommended a gradual dose reduction (GDR). This placed the resident at risk for harm including negative side effects of the psychotropic medication, experiencing a fall, mental status changes, or sustained negative psychosocial outcomes. The medical record did not show evidence that the attending physician had reviewed and responded to the pharmacist MRR recommendation. …
F756 citations in Hawaii
Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Hawaii cites F756 more often than its own record predicts
2.14 times the share F756 takes of citations nationally.
Of every deficiency written in Hawaii in 2025, this is the portion that was F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Hawaii surveyors wrote
F756 findings written in Hawaii, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on record review and interview, the facility failed to ensure the attending physician documented review of the consultant pharmacist's monthly medication regimen review (MRR) recommendations, including actions taken in response to the pharmacist's recommendations, for one of five residents (Resident (R) 5) reviewed for unnecessary medications. This deficient practice placed R5 at risk for unresolved medication-related concerns, including adverse drug reactions, medication interactions, continued use of unnecessary medications, ineffective treatment, and potential decline in health status. …
The short window
Recent years
| Year | Share of Hawaii citations | vs expected |
|---|---|---|
| 2023 | 1.48% | 1.57× |
| 2024 | 1.11% | 1.36× |
| 2025 | 1.69% | 2.14× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Hawaii surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction